Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2016 Aug;38(6):429–436. doi: 10.1097/MPH.0000000000000555

Table 1.

Treatment and demographic characteristics of survivors of pediatric acute lymphoblastic leukemia at Texas Children's Hospital

BMI Class at Follow up
Overall (n=406) Underweight (n=11) Normal (n=193) Overweight (n=112) Obese (n=90)

Subtype, n(%)1
    B-cell lineage 27 (6.8) 9 (90.0) 169 (90.9) 96 (87.3) 82 (91.1)
    T-cell lineage 357 (89.9) 1 (10.0) 9 (4.8) 12 (10.9) 5 (5.6)
    Infantile 13 (3.3) 0 (0.0) 8 (4.3) 2 (1.8) 3 (3.3)
Age at Diagnosis, n(%)
    0-5 years 263 (64.8) 7 (63.6) 132 (68.4) 70 (62.5) 54 (60.0)
    6-10 years 98 (24.1) 3 (27.3) 39 (20.2) 29 (25.9) 27 (30.0)
    11-18 years 45 (11.1) 1 (9.1) 22 (11.4) 13 (11.6) 9 (10.0)
    Mean, year (sd) 5.44 (3.71) 5.58 (2.62) 5.33 (3.87) 5.53 (3.85) 5.55 (3.33)
Diagnosis BMI, z-score (sd)2 0.21 (1.29) −1.79 (1.31) −0.23 (1.13) 0.56 (1.21) 1.05 (1.01)
Race/Ethnicity, n(%)
    Non-Hispanic white 199 (49.0) 8 (72.7) 110 (57.0) 52 (46.4) 29 (32.2)
    Hispanic 157 (38.7) 1 (9.1) 60 (31.1) 53 (47.3) 43 (47.8)
    Non-Hispanic black 24 (5.9) 0 (0.0) 9 (4.7) 3 (2.7) 12 (13.3)
    Other 26 (6.4) 2 (18.2) 14 (7.2) 4 (3.6) 6 (6.7)
Gender, n(%)
    Female 186 (45.8) 7 (63.6) 96 (49.7) 39 (34.8) 44 (48.9)
    Male 220 (54.2) 4 (36.4) 97 (50.3) 73 (65.2) 46 (51.1)
CRT, n(%)3
    None 360 (89.1) 9 (81.8) 180 (93.7) 94 (84.7) 77 (85.6)
    ≤18 Gy 27 (6.7) 2 (18.2) 8 (4.2) 12 (10.8) 5 (5.6)
    ≥24 Gy 17 (4.2) 0 (0.0) 4 (2.1) 5 (4.5) 8 (8.8)
Year of diagnosis, n(%)
    1972-1994 89 (21.9) 1 (9.1) 40 (20.7) 25 (22.3) 23 (25.6)
    1995-2008 317 (78.1) 10 (90.9) 153 (79.3) 87 (77.7) 32 (74.4)
Age at follow-up, n(%)
    ≤ 10 years 42 (10.3) 0 (0.0) 23 (11.9) 23 (20.5) 16 (17.8)
    11-20 years 260 (64.0) 9 (81.8) 132 (68.4) 64 (57.1) 51 (56.7)
    21-30 years 92 (22.7) 1 (9.1) 34 (17.6) 22 (19.6) 19 (21.1)
    ≥ 31 years 12 (3.0) 1 (9.1) 4 (2.1) 3 (2.7) 4 (4.4)
    Mean, year (sd) 16.83 (5.94) 16.35 (6.05) 16.86 (5.79) 16.68 (6.13) 17.04 (6.08)
Time fom diagnosis, year (sd) 11.39 (5.33) 10.77 (5.17) 11.53 (4.93) 11.14 (5.86) 11.48 (5.54)
Treatment duration, year (sd) 2.84 (1.33) 3.06 (1.39) 2.74 (1.25) 3.02 (1.54) 2.83 (1.17)

BMI, Body Mass Index; SD, Standard Deviation; CRT, Cranial Radiation Therapy

1

Missing subtype information on n=10

2

Restricted to patients with height and weight recorded at diagnosis (n=292)

3

Missing radiation dose information on n=2 radiated participants